Tower Research Capital LLC (Trc) Solid Biosciences Inc. Transaction History

Tower Research Capital LLC (Trc)

$3.68 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	SELL	$0.51 - $7.56 $335 - $4,966	-657 Reduced 2.59%	24,687 $12,000
Q2 2022 Aug 15, 2022	BUY	$0.43 - $1.24 $7,147 - $20,611	16,622 Added 190.58%	25,344 $16,000
Q1 2022 May 12, 2022	SELL	$0.74 - $1.79 $26,409 - $63,883	-35,689 Reduced 80.36%	8,722 $10,000
Q4 2021 Feb 14, 2022	BUY	$1.69 - $2.46 $41,582 - $60,528	24,605 Added 124.23%	44,411 $78,000
Q3 2021 Nov 15, 2021	BUY	$2.38 - $3.77 $26,729 - $42,340	11,231 Added 130.97%	19,806 $47,000
Q2 2021 Aug 16, 2021	SELL	$3.49 - $5.51 $90,359 - $142,659	-25,891 Reduced 75.12%	8,575 $31,000
Q1 2021 May 17, 2021	BUY	$5.37 - $10.72 $161,481 - $322,361	30,071 Added 684.21%	34,466 $190,000
Q4 2020 Feb 16, 2021	SELL	$3.08 - $7.79 $72,179 - $182,558	-23,435 Reduced 84.21%	4,395 $33,000
Q3 2020 Nov 16, 2020	BUY	$2.02 - $3.08 $46,009 - $70,153	22,777 Added 450.76%	27,830 $57,000
Q2 2020 Aug 13, 2020	BUY	$2.1 - $3.42 $10,611 - $17,281	5,053 New	5,053 $15,000
Q1 2020 May 15, 2020	SELL	$2.31 - $4.43 $30,833 - $59,131	-13,348 Closed	0 $0
Q4 2019 Feb 07, 2020	BUY	$2.82 - $12.9 $34,962 - $159,934	12,398 Added 1305.05%	13,348 $59,000
Q3 2019 Nov 05, 2019	BUY	$4.33 - $11.64 $4,113 - $11,058	950 New	950 $10,000
Q1 2019 May 14, 2019	SELL	$7.19 - $32.37 $20,218 - $91,024	-2,812 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$21.32 - $46.34 $59,951 - $130,308	2,812 New	2,812 $75,000
Q3 2018 Nov 13, 2018	SELL	$36.35 - $51.7 $16,175 - $23,006	-445 Closed	0 $0
Q2 2018 Aug 15, 2018	SELL	$7.33 - $43.15 $16,968 - $99,892	-2,315 Reduced 83.88%	445 $16,000
Q1 2018 May 15, 2018	BUY	$7.19 - $33.17 $19,844 - $91,549	2,760 New	2,760 $21,000

Others Institutions Holding SLDB

# of Institutions

Shares Held

Call Options Held

Put Options Held

View Full List

About Solid Biosciences Inc.

Ticker SLDB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 7,533,080
Market Cap $29.8M
Description
Solid Biosciences Inc. engages in developing therapies for duchenne muscular dystrophy in the United States. The company's lead product candidate is SGT-001, a gene transfer candidate, which is in a Phase I/II clinical trial to drive functional dystrophin protein expression in patients' muscles; and SGT-003, a ext-generation gene transfer candid...

More about SLDB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Account